Legal Representation
Attorney
ALBERT P. HALLUIN
USPTO Deadlines
Application History
47 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 10, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Aug 10, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Jan 6, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 6, 2009 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jan 6, 2009 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jul 1, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 1, 2008 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 1, 2008 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 7, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 7, 2008 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 7, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Sep 9, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 3, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 3, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Mar 13, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jan 5, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 5, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 11, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 18, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 29, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Mar 3, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 24, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 22, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 22, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 14, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 14, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 6, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 6, 2005 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 2, 2005 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Aug 15, 2005 | CWBP | Z | WITHDRAWN BEFORE PUBLICATION | Loading... |
Jul 26, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jul 22, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jul 21, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 20, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 11, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 11, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 9, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 9, 2005 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 1, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
Jan 31, 2005 | I | PAPER RECEIVED | Loading... | |
Jan 31, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 5, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Aug 21, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 12, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 20, 2004 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Jul 16, 2004 | I | PAPER RECEIVED | Loading... | |
Feb 2, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical diagnostic and therapeutic preparations for clinical use, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold as a kit, namely inhalers; medical preparations namely nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005